Clinical Characteristics of Lymphatic Malformations
Sponsored by West China Hospital
About this trial
Last updated 2 years ago
Study ID
2024-127
Status
Completed
Type
Observational
Placebo
No
Accepting
All Ages
All Sexes
Trial Timing
Ended 2 years ago
What is this trial about?
The primary purpose of this study is to retrospectively identify the clinical characteristics of abdominal lymphatic malformations (ALMs) in our single center in China. The second objective of this study is to retrospectively compare the epidemiological features, clinical presentations, cyst properties, surgical treatments, and risk factors for preoperative complications of ALMs between paediatric participants and adult participants.
What are the participation requirements?
Inclusion Criteria
* The investigators enrolled participants who were pathologically diagnosed with lymphangioma or lymphatic malformations in the abdominal cavity (i.e., abdominal lymphatic malformations) from January 2009 to December 2022 at our institution.
Exclusion Criteria
* The investigators excluded participants without a pathological diagnosis of abdominal lymphatic malformations through resection specimens and those with pathological confirmation of other diseases, as well as patients with complex lymphatic anomalies.